Revolution Medicines' Rasonque Hits $198 Million in First Quarter

Revolution Medicines' Rasonque pulled in $198 million in its first five weeks, crushing the $24.9 million estimate. Jefferies sees $3.1 billion in sales next year for the pancreatic cancer drug.